Recently, MicroPort^® CardioFlow’s VitaFlow Liberty^® Transcatheter Aortic Valve and Rretrievable Delivery System (hereinafter referred to as "VitaFlow Liberty^®"),stood out from numerous works around the world with its innovative design concept and excellent product performance, and successfully won the 2022 German Red Dot Design Award (product design).

Shanghai, China - MicroPort^® CardioFlow Medtech Corporation (hereinafter referred to MicroPort^® CardioFlow ,02160.HK) announced that its self-developed Alwide^® Plus balloon catheter (hereinafter referred to as "Alwide^® Plus") has been approved by the Argentine National Administration of Drugs, Foods, and Medical Devices (ANMAT).

Shanghai, China - MicroPort^® CardioFlow Medtech Corporation (hereinafter referred to as MicroPort^® CardioFlow", stock code: 02160.HK) announced that its self-developed VitaFlow Liberty^® Transcatheter Aortic Valve and Retrievable Delivery System (hereinafter referred to as "VitaFlow Liberty^®"), a new generation product for Transcatheter Aortic Valve Implantation (TAVI), has been approved by the Argentine National Administration of Drugs, Foods, and Medical Devices (ANMAT).